View publication

↩ Back to all publications
Publication
PropertyValue
Working Groups AG Cyganek, AG Hasenfuß, AG Wollnik, AG Zelarayan, AG Zimmermann
SubprojectC04, C07, D01, D02, S01
Open AccessOpen Access Yes
Publication TypeJournal Article
Peer ReviewedYes
PMIDPubMed ID 38333672
DOIDOI 10.1016/j.omtn.2024.102123
Publication Year2024
TitlePreclinical evaluation of CRISPR-based therapies for Noonan syndrome caused by deep-intronic LZTR1 variants
JournalMolecular Therapy-Nucleic Acids
ISSN2162-2531
eISSN2162-2531
URL http://dx.doi.org/10.1016/j.omtn.2024.102123
Pages102123
Issue1
Volume35
Journal AbbreviationMol Ther-Nucl Acids
AuthorsKnauer C, Haltern H, Schoger E, Kügler S, Roos L, Zelarayán LC, Hasenfuss G, Zimmermann W, Wollnik B, Cyganek L
First AuthorKnauer C
Last AuthorCyganek L

 External Resources

 829  Published Data Registry entry (MBExC)

 1/399  Research Data Archive MBExC (supplemental material)

 01s1h3j07  ROR identifier (01s1h3j07, Fraunhofer Institute for Translational Medicine and Pharmacology)

 031t5w623  ROR identifier (031t5w623, German Centre for Cardiovascular Research)

 043j0f473  ROR identifier (043j0f473, German Center for Neurodegenerative Diseases)

 05xy1nn52  ROR identifier (05xy1nn52, Multiscale Bioimaging)

 021ft0n22  ROR identifier (021ft0n22, University Medical Center Göttingen)

 033eqas34  ROR identifier (033eqas34, University of Giessen)

 Q129438068  Wikidata ID